Lilly Asia Ventures (LAV) is a healthcare focused venture capital and private equity firm based in Shanghai and Hong Kong. LAV's investment strategy is industry specific but stage agnostic. Major coverage areas include biopharmaceuticals, medical devices, diagnostics, healthcare services, and health IT.

Visit website

CYBER MONDAY: 25% Off tickets until 6 December using the code: CYBER25

Partners & Attendees

Intel.001
Acc1.001
Rbc research.001
Kd nuggets.001
Mit tech review.001
Nvidia.001
Twentybn.001
Ibm.001
Maluuba 2017.001
Facebook.001
Forbes.001
Graphcoreai.001
This website uses cookies to ensure you get the best experience. Learn more